A randomized trial of staphylococcus aureus prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin
- 31 May 1996
- journal article
- clinical trial
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 27 (5) , 695-700
- https://doi.org/10.1016/s0272-6386(96)90105-5
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Infecting Organisms in Continuous Ambulatory Peritoneal Dialysis Patients on the Y-setAmerican Journal of Kidney Diseases, 1994
- Treatment of Staphylococcus aureus Nasal Carriers in Continuous Ambulatory Peritoneal Dialysis With Mupirocin: Long-term ResultsAmerican Journal of Kidney Diseases, 1993
- Side-effects of desferrioxamine in dialysis patientsNephrology Dialysis Transplantation, 1993
- Elimination of Coincident Staphylococcus aureus Nasal and Hand Carriage with Intranasal Application of Mupirocin Calcium OintmentAnnals of Internal Medicine, 1991
- A Review of Staphylococcu S aureus Exit-Site and Tunnel Infections in Peritoneal Dialysis PatientsAmerican Journal of Kidney Diseases, 1990
- Mupirocin for the reduction of colonization of internal jugular cannulae—a randomized controlled trialJournal of Hospital Infection, 1990
- Staphylococcus aureus Nasal Carriage and Infection in Patients on Continuous Ambulatory Peritoneal DialysisNew England Journal of Medicine, 1990
- Long-Term Survivors on Peritoneal DialysisAmerican Journal of Kidney Diseases, 1987
- Staphylococcus aureusNasal Carriage and Infection in Patients on HemodialysisNew England Journal of Medicine, 1986
- Staphylococcal nasal carriage and subsequent infection in peritoneal dialysis patientsJAMA, 1982